Search results
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 8 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV recently announced that it has acquired UK-based private biotech, DJS Antibodies...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 1 week agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 5 days agoAbbVie has announced that its RINVOQ (upadacitinib) is now indicated for treating polyarticular...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 4 days agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of...